baber/WOPTO huggingface dataset:
Patent NZ-506432-A (NZ)
Title: 2-(2,6-dioxopiperidin-3-yl) isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
Inventor: MAN HON-WAH
IPC: A61P1/04
Filed: 1999-03-16
Abstract: 1-Oxo- and 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindolines of formula (I) in which Y is oxygen or H2, one of R<1> and R<2> is halo, alkyl, alkoxy, alkylamino, dialkylamino, cyano, or carbamoyl, the other of R<1> and R<2> is independently hydrogen, halo, alkyl, alkoxy, alkylamino, dialkylamino, cyano, or carbamoyl and; R<3> is hydrogen, alkyl, or benzyl, and the method of reducing levels of tumor necrosis factor alpha and other inflammatory cytokines in a mammal through the administration of such derivatives, and pharmaceutical compositions containing such derivatives.
Patent NZ-507672-A (NZ)
Title: Apparatus and methods of forming a curved structure
Inventor: WHEELER FRANKLIN L
IPC: E04G21/00
Filed: 1998-04-24
Abstract: An apparatus (10) for forming curved structures, comprises: a plurality of sections (12), each section has a base portion (14) and a first track portion (16), a plurality of vertical slots (40) disposed through the first track portion, a connection (20) pivotally attached to the base portions of adjacent sections, and a first strap member (24) slidably engaging the plurality of vertical slots disposed through the first track portion of the sections such that the sections are movable to form a radius of curvature.
Patent NZ-509111-A (NZ)
Title: Electrical connection of conductive fibers at ends of safety-monitored synthetic fiber ropes
Inventor: ANGELIS CLAUDIO DE
IPC: H01R13/713
Filed: 2000-12-21
Abstract: The overstress or breakage indicating conductive fibers in an otherwise insulating synthetic fiber rope are connected conductively together at the end of the rope by a contacting element fastened to the end of the rope.  The contacting element may be a mechanically fixed element 13 or a blob of electrically conductive adhesive 52 applied to the end of the rope.
Patent NZ-509583-A (NZ)
Title: Amine salts of HMG-CoA reductase inhibitors used to purify HMG-CoA reductase inhibitors
Inventor: PFLAUM ZLATKO
IPC: C07C211/10
Filed: 1999-09-17
Abstract: A salt of an HMG-CoA reductase inhibitor has an amine of the formula (I) or (II) wherein: a1) R1 to R4 are independently hydrogen, alkyl, cycloalkyl, optionally substituted arylalkyl group (where the alkyl group is methyl or ethyl and the aryl group is phenyl), arylalkyl, hydroxyalkyl or aminoalkyl; X is hydrogen, hydroxyl, halogen or methyl and m and n are independently 0 to 5 or a2) NR1R2 or NR3R4 is a heterocyclic ring having 3 to 7 methylene groups, one of these groups being optionally substituted by oxygen or sulfur or imine and X, m and n are the same as defined above; b1) R'1, R'2, and R'3 are independently hydrogen or optionally substituted alkyl or alkenyl, provided that R'1, R'2, and R'3 are not hydrogen at the same time or b2) R'1 and R'2, and optionally R'3 together with the nitrogen atom form a heterocyclic ring system including the nitrogen atom as a ring member, and optionally including an additional hetero atom, and if R'3 is not part of the ring system it is independently hydrogen, alkenyl or optionally substituted alkyl or b3) R'1 is R'-(CHR'4)m- (formula (III) and R'2 and R'3 are the same as R'1 or hydrogen, alkenyl or optionally substituted alkyl, or b4) R'1 is an optionally substituted -(CHR'5)m-phenyl (formula IV) and R'2 and R'3 are independently hydrogen or optionally substituted alkyl or can be a group of the same formula as R'1 as defined above; m is 0 to 5; R' is an optionally substituted aliphatic hydrocarbon cyclic system having 3 to 8 carbon atoms in the ring; R'4 is hydrogen or optionally substituted alkyl or can be a group of the same formula as R'1 as defined above and R'5 is hydrogen or one or more substituents provided that: i) when the HMG-CoA reductase inhibitor is lovastatin, the amine is not tetramethylamine or ethylenedianine, ii) when the HMG-CoA reductase inhibitor is tetrahydro-M4 or tetrahydro-IsoM-4, the amine is not octylamine, 2- ethylhexylamine, benzylamine, a-methyl-benzylamine, phenethylamine, dibenzylamine, N-methylbenzylamine, N,N- dimethylbenzylamine, N,N-diethylbenzylamine, N-ethyl-N- methylbenzylamine, tribenzylamine, cyclopentylamine, cyclohexylamine, cycloheptylamine, N-methylcyclopentylamine, N-ethylcyclohexylamine, N-ethylcycloheptylamine, dicyclohexylamine, N,N-dimethylcyclopentylamine, N,N- dimethylcyclohexylamine, N,N-diethylcycloheptylamine, pyrrolidine, N-methylpyrrolidine, piperidine, N- methylpiperidine or morpholine; or iii) when the HMG-CoA reductase inhibitor is the octahydronaphthalene oxime derivative of ML-236A, ML-236B, MB-530A or MB-530B, the amine is not t-octylamine, dibenzylamine, dicyclohexylamine or morpholine.
Patent NZ-510478-A (NZ)
Title: Inhaler
Inventor: CHRISTRUP SOREN
IPC: A61M15/00
Filed: 1999-09-24
Abstract: The actuation mechanism of a breath-actuated inhaler for delivery of a medicament by inhalation. The actuation mechanism includes a pre-loading mechanism is arranged to load the resilient loading element by manual depression of two contact members movable relative to the housing and disposed opposite one another on either side of the axis of a canister held in the housing. The actuation mechanism also includes a pivotably mounted trigger vane arranged to be moved by inhalation at the mouthpiece to cause operation of the actuation mechanism, wherein the trigger vane is mounted to pivot about an axis passing through the centre of mass of the trigger. The triggering mechanism comprises a knee joint having a locked position where the knee joint holds the resilient loading element against compression of the canister and a trigger responsive to the inhalation at the mouthpiece to break the knee joint into a broken position where the knee joint releases the resilient loading element to allow compression of the canister. Furthermore the trigger comprises a second knee joint connected to the first-mentioned knee joint and having a locked position where the second knee joint holds the first knee joint in its locked position and movable in response to inhalation at the mouthpiece to a broken position to break the first knee joint
Patent NZ-520777-A (NZ)
Title: Distribution of music data utilising a high-speed satellite link between user and music content distributor
Inventor: SPARKS KELLY C
IPC: G06Q30/00
Filed: 2001-01-22
Abstract: A system for distributing music (10) selections to customer households comprises: (a) a data transmission system blanket transmitting (20) a plurality of music selections to customer households in digital form at faster than real time speeds; (b) a user station (28) at each of a plurality of customer households, which includes: means for permitting the customer household to preselect desired transmitted music selections for recording; (c) a receiver (110) and associated high capacity storage medium (130) for storing music selections in digital form; (d) a removable media read/write device for creating copies of music selections stored on the high capacity storage medium on removable media; (e) a central controller system (36) which has a database for storing therein an address corresponding to each customer household; (f) a communications link (38) between customer households and the central controller system; and (g) a billing system (140 ) associated with the central controller system for receiving music playback or recording information from customer households via the communications link and billing customer households for the privilege of playing back music selections from the high capacity storage medium or for the privilege of recording music selections onto removable media.
Patent NZ-520802-A (NZ)
Title: Compositions useful for regulating parkin gene activity
Inventor: KOUTNIKOVA HANA
IPC: A61K45/00
Filed: 2001-02-15
Abstract: Compound capable of modulating, at least partially, the interaction between the PAP1 protein, or a homolog thereof, and parkin. Also disclosed are pharmaceutical compounds comprising at least one such compound and the use of such a compound in the manufacture of a medicament for use in treating neurodegenerative pathologies.
Patent NZ-522019-A (NZ)
Title: GLAST-1a: a GLAST-1 splice variant where exon 3 has been removed
Inventor: MASON DEBORAH
IPC: A61P17/02
Filed: 2001-03-26
Abstract: Described  is the Na+ dependent glutamate  transporter GLAST-1  and  a  splice  variant  thereof.  A  novel  splice variant  has  been  found  (GLAST-1a)  which  lacks  exon  3 resulting in a loss of about 46 amino acids. The protein  is altered  in  such a way that indicates altered  function  of the  transporter.  Indeed, the inventors  have  surprisingly determined that the splice variant has a reversed  transport direction  as  compared  to  GLAST-1.  Thus,  the  invention provides  materials  and  methods  relating  to  the  splice variant  GLAST-1a including the amino acid and nucleic  acid sequence;  materials and methods relating to  the  detection in  vivo  or  in  vitro of the GLAST-1a; and  materials  and methods  relating  to  the modulation  of  excitatory  amino acids (EAAs) signalling.
Patent NZ-525025-A (NZ)
Title: Co-processed organic and inorganic yellow pigments
Inventor: VALIN ROLAND J
IPC: C09B67/22
Filed: 2001-09-25
Abstract: A yellow pigment composition containing at least one yellow nickel titanate and at least one yellow organic pigment containing a benzimidazolone moiety is disclosed. A method of making a yellow pigment composition involving the steps of combining at least one yellow nickel titanate and at least one yellow benzimidazolone pigment to form a mixture; and mixing the mixture to form a homogenous mixture of the yellow pigment composition is also disclosed.
Patent NZ-526872-A (NZ)
Title: Drainage system for pouch for collecting human waste
Inventor: FALCONER MALCOLM
IPC: A61F5/44
Filed: 2003-07-04
Abstract: A drainable ostomy pouch (10) has an outlet (22). Reinforcing members (32, 34) at the outlet (22) are deformable by application of manual pressure at their ends to distend the outlet (22). The lateral edges of the reinforcing members (32, 34) may be offset, which encourages the reinforcing members to consistently bend away from each other. A peelable distributed mechanical engagement fastener (46) secures the outlet (22) in a folded condition. The fastener parts (46a and 46b) are hook-hook type plastic extrusions, and provide a snap-engagement. A security flap (50) is foldable under the outlet (22) when in its folded condition. The outlet is released in two stages.
Patent NZ-529466-A (NZ)
Title: Water-soluble extract from plants of solanum genus, particularly S. incanum and S. nigrum, the preparation process thereof and pharmaceutical compositions for inhibiting cancer/tumour cell growth
Inventor: KUO KOU-WHA
IPC: A61P35/00
Filed: 2003-11-11
Abstract: Described is a water soluble extract from plant of the Solanum genus, which consists of at least 60-90% of solamargine and solasonine and a process for preparing the water soluble plant extract comprising the steps of: a) subjecting plant material from a plant of the Solanum genus to an extraction treatment using an acidic aqueous solution with a pH of 3-5, such that an aqueous solution is obtained; b) adjusting the pH of the solution from step a) to pH 8-10 with a base, such that a precipitate is formed; c) washing the precipitate from step b) with water, followed by drying, such that a dried product is obtained; d) admixing the dried product from step c) with chloroform, followed by addition of a suitable amount of a 100% alcohol, such that a chloroform-alcohol mixture is formed; e) mixing the chloroform-alcohol mixture from step d) with a water/alcohol solution having a predetermined water/alcohol ratio, such that a mixture containing a chloroform-based layer and a non chloroform-based layer is obtained, and; f) removing the chloroform-based layer from the mixture obtained from step e) followed by the addition of a suitable amount of water, and; g) obtaining a supernatant from the resultant mixture of step f) followed by drying the supernatant, such that the resultant dried product is able to be directly dissolved in water to form a yellowish clear transparent aqueous solution. The figureshows a HPLC spectrum of the water-soluble extract from the fruit of Solanum incanum L.. The first peak corresponds to solasonine and the second peak corresponds to solamargine, and the content of solamargine is greater than that of solasonine.
Patent NZ-530421-A (NZ)
Title: Hyaluronan derivatives with esterfied or carbamoylated hydroxyl groups to be used in chiral stationary phases for seperation of enantiomers
Inventor: MARIOTTI PAOLO
IPC: C07B57/00
Filed: 2002-06-03
Abstract: Disclosed herein are derivatives of hyaluronan, wherein the hydroxyl groups are either esterified or carbamoylated in amounts ranging from 0.01% to 100% and the carboxyl groups are either totally or partially esterified with alcohols or they are in the form of salt, with the exception of the benzylester of acetylated hyaluronan, the salt of acetylated hyaluronan, the salt of butyrated hyaluronan, and provided that when the hydroxyl groups are esterified the carboxyl groups are totally or partially esterified with alcohols. These derivatives of hyaluronan that have the intrinsic viscosity in the range from 0.1 to 22 dl/g, are useful in the preparation of chromatographic stationary phases or chiral stationary phases.
Patent NZ-530570-A (NZ)
Title: Keratin-based products and methods for their productions
Inventor: SCHROOYEN PETER MARCEL MYRIAM
IPC: C12P21/06
Filed: 2002-07-12
Abstract: A process for producing partially modified and partially hydrolysed keratin, the process comprises the steps of (a) solubilising keratin from a keratin-fibre containing starting material in an aqueous solution using a reducing agent at alkaline pH, and (b) partially modifying the SH groups of the solubilised keratin by alkylation, characterised in that the solubilised keratin is partially hydrolysed as a result of the conditions of steps (a) and (b) and an optional further hydrolysis step (c), whereby the solubilised keratin is partially hydrolysed such that at least 50% of the solubilised keratin molecules has a molecular weight higher than 1 kDa and less than 10.4 kDa and whereby the solubilised keratin has molecular weight distribution that is essentially equal to a distribution of molecular weights of keratin that is obtained when 40 grams of cleaned and dried poultry feathers are solubilised in one litre of an aqueous solution of 0.05-0.5 M sodium sulphide at a pH between pH 10.0 and pH 13.5, at a temperature between 40 and 80°C for 30-90 minutes.
Patent NZ-533357-A (NZ)
Title: Infusion pump
Inventor: KELLER HERMANN L
IPC: A61M5/142
Filed: 2002-11-06
Abstract: Known variable flow pumps (VF pumps) are characterised by significant inaccuracies in the delivery quantities. In addition, they cause cosmetic problems in the carrier after implantation as a result of their external configuration. Provided is an implantable VF pump, which resolves said disadvantages. To achieve this, the battery-driven delivery device is configured according to piezoelectric principles and the external surface of the upper pump housing shell is provided with expansion joints.
Patent NZ-543281-A (NZ)
Title: Resuscitation training manikin
Inventor: LAERDAL TORE
IPC: G09B23/28
Filed: 2004-05-07
Abstract: A manikin for practising resuscitation, comprising an inflatable body (1) having substantially the shape of at least an upper part of the human body, comprising a chest (5) and a head (7). The inflatable body has means for retaining air or gas in the inflatable body when deformed by compression force exerted during simulated chest compression. The inflatable body has means for deflation of the inflatable body when not in use.
Patent NZ-544375-A (NZ)
Title: Food packaging using a polyolefin film.
Inventor: KVAMME LARS INGE
IPC: B32B27/32
Filed: 2004-06-18
Abstract: Disclosed is a method for the packaging of meat or seafood in which the meat or seafood is packaged on a packaging line using a multilayer film having at least a first layer and a sealing layer, said first layer comprising a heterophasic polypropylene block copolymer and said sealing layer comprising a polyethylene polymer wherein the package is frozen immediately after packaging.
Patent NZ-547717-A (NZ)
Title: An animal supplement and method of manufacture
Inventor: DAVIS KATHRINE BRIDGET
Filed: 2006-06-06
Abstract: Disclosed is a method of manufacturing a liquid formulation for oral administration to provide an animal with at least one trace element and/or vitamin by the steps of: (a) producing a solution containing: (i) the trace element/s or vitamin/s selected from one or more of the following: at least one water soluble selenium source; at least one water soluble iodine source; ascorbic acid; and (ii) at least one sugar alcohol based non-aqueous liquid to semi-liquid carrier; (b) producing a solution containing at least one vitamin oil selected from: vitamin A, vitamin D, vitamin E, and combinations thereof; wherein the vitamin oil or oils are characterised by being substantially water immiscible; (c) mixing the solution of step (a) with the solution of step (b).
Patent NZ-560285-A (NZ)
Title: Use of baff to treat Th2-mediated conditions
Inventor: MACKAY CHARLES
IPC: A61K38/19
Filed: 2006-01-27
Abstract: Provided is the use of a soluble BAFF (B cell activating factor belonging to the TNF family) polypeptide in the preparation of a medicament for the treatment of Th2-mediated disorder or a condition characterized by an inadequate Th1 response. The peptide can be used to treat viral of intracellular bacterial pathogens.
Patent NZ-560662-A (NZ)
Title: Use of EDG receptor binding agents in cancer
Inventor: BAUMRUKER THOMAS
IPC: A61P43/00
Filed: 2003-05-15
Abstract: Disclosed is the use of a S1P receptor agonist of formula I wherein the substituents are disclosed within the specification or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for preventing or treating a lymphoproliferative or myeloproliferative disorder, wherein the medicament is adapted for administration with a chemotherapeutic agent.
Patent NZ-562503-A (NZ)
Title: Apparatus for and method of lining conduits
Inventor: GRAHAM NEIL DERYCK BRAY
IPC: B29C63/36
Filed: 2003-09-02
Abstract: An apparatus for lining an internal surface of a conduit is disclosed. The apparatus includes a body that is adapted to be progressively moved along the conduit, a flexible tube structure undergoing eversion within the conduit for installation thereof onto the internal surface of the conduit, where the body presents a contact surface against which the tube structure acts during eversion. Also provided are means for sensing and/or monitoring selected conditions associated with installation of the flexible tube structure and means for varying installation as necessary in response to such conditions.
Patent NZ-566766-A (NZ)
Title: A refrigeration system including independently operable drawers
Inventor: SMITH WILLIAM E
IPC: F25B29/00
Filed: 2007-01-12
Abstract: A storage system that has variable temperature includes one or more drawers (15). The one or more drawers are independently operable of one another. A heating and cooling system (70, 75) is in thermal communication with the one or more drawers. The heating and cooling system generates even air-flow (A, B) around all sides of the one or more drawers for heating and/or cooling thereof.
Patent NZ-570561-A (NZ)
Title: Battery charger
Inventor: BARR JASON M
IPC: H02J7/00
Filed: 2007-02-20
Abstract: A battery charger is disclosed which comprises a battery pod for holding batteries for transport and charging. The battery pod comprises: a body configured to be transported by a consumer and received by a charging bay; a battery receiving region defined within the body and configured to receive a plurality of batteries including at least one of AAA, AA, C and D sized batteries; and a cover attached to the body and moveable to an open position and a closed position. The plurality of batteries may be removed from the battery pod with the cover in the open position and installed in an external device for powering of the external device. A first charging bay receives the battery pod and provides charging energy to the first battery pod to charge the first plurality of batteries.
Patent NZ-571280-A (NZ)
Title: Deuterated hepatitis C protease inhibitors
Inventor: PERNI ROBERT B
IPC: C07C237/04
Filed: 2007-03-14
Abstract: Disclosed is a keto-enriched alpha-ketoamido compound represented by general formula (I) wherein D is a deuterium atom. Also disclosed is the use of the compounds of formula (I) for treating hepatitis C virus (HCV) infection or a condition mediated by HCV protease
Patent NZ-573496-A (NZ)
Title: Stump grinder head
Inventor: CROXTON DAVID JAMES
IPC: B27C5/00
Filed: 2010-03-08
Abstract: Disclosed is an apparatus for supporting at least one cutter tooth. The cutter tooth support apparatus is adapted in use for removable attachment to a rotatable grinder plate having side surfaces and an edge perimeter. The body of the apparatus has at least one slot or pocket with an entrance, the slot is shaped and adapted when in use to hold at least one tooth.
Patent NZ-582705-A (NZ)
Title: Therapeutic substituted cyclopentanes for reducing intraocular pressure
Inventor: OLD DAVID W
IPC: A61K31/5575
Filed: 2008-06-30
Abstract: Disclosed are cyclopentane compounds represented by general formula (I) such as: 5-(3-((1R,2R,3R,5R)-5-chloro-2-(3,5-dichlorostyryl)-3-hydroxycyclopentyl)prop-1-enyl)thiophene-2-carboxylic acid; 5-(3-((1R,2R,3R,5R)-5-chloro-2-(3-chloro-5-(hydroxymethyl)styryl)-3-hydroxycyclopentyl)propyl)-thiophene-2-carboxylic acid; and 5-(3-((1R,2R,3R,5R)-5-chloro-2-((E)-2-(5-chloropyridin-3-yl)vinyl)-3-hydroxycyclopentyl)propyl)-thiophene-2-carboxylic acid; The compounds are used to treat intraocular pressure.
Patent NZ-583020-A (NZ)
Title: A motion reducing apparatus for ship with a safety cutoff for the motor based on the temperature of the dampers
Inventor: TAKEUCHI HIROSHI
IPC: B63B39/04
Filed: 2010-02-01
Abstract: A swing motion reducing apparatus (10) for a ship is disclosed. The apparatus has flywheel (11), a gimbal mechanism (12) configured to support the flywheel (11) and a motor (13) configured to rotate the flywheel (11) when supplied power by a motor drive. A damper section (15A, 15B) is configured to brake any swing motion of the gimbal mechanism (12) which produces heat in the damping material. If the temperature of the damper section (15A, 15B) is equal to or higher than a predetermined temperature a safety unit, that controls the motor driver, stops the supply of the drive power to the motor (13). A high temperature may be indicative of a damaged damper section (15A, 15B) so cutting power to the motor (13) can help prevent damage to the apparatus (10) as a whole. The temperature may be sensed by bi-metallic switches mounted to the outer casing of the damper section (15A, 15B).
Patent NZ-585705-A (NZ)
Title: Method to inspect a blade using computer tomography
Inventor: STIESDAL HENRIK
IPC: A61B6/03
Filed: 2010-05-26
Abstract: Disclosed is a method of inspecting a blade (BL) of a wind-turbine. The method includes: at least parts of the blade being inspected by a computer-tomography-method using radiation, the radiation being directed through the blade by a transmitter (AS, BS) and received by a receiver (AR, BR) after it has passed through the blade. The position of the transmitter, of the receiver, and/or of the blade is changed in relation to each other to perform the inspection of the blade. A tilt-angle of the transmitter and/or of the receiver in reference to the blade is adjusted to improve the results of the inspection.